✦ LIBER ✦

Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective

✍ Scribed by T.R. EINARSON; S.R. ARIKIAN; N.H. SHEAR

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis: cardiovascu

✍ S. D. Saini; A. M. Fendrick; J. M. Scheiman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Cost-effectiveness of letrozole versus t

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

A Model for valuation of government expo

✍ Haydée Calderón; Teresa Fayós; Amparo Cervera 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Cost-Effectiveness of Hormone Replacemen

✍ R. Fleurence; D. J. Torgerson; D. M. Reid 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 131 KB

Cost-effectiveness analysis of TNF-α blo

✍ Simona de Portu; Micol Del Giglio; Gianfranco Altomare; Fabio Arcangeli; Enzo Be 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Posaconazole versus fluconazole or itrac

✍ George Dranitsaris; Haytham Khoury 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 217 KB